Safety considerations for nanoparticle gene delivery in pediatric brain tumors

Kathryn M. Luly, John Choi, Yuan Rui, Jordan J. Green, Eric M. Jackson

Research output: Contribution to journalArticlepeer-review

Abstract

Current standard of care for many CNS tumors involves surgical resection followed by chemotherapy and/or radiation. Some pediatric brain tumor types are infiltrative and diffuse in nature, which reduces the role for surgery. Furthermore, children are extremely vulnerable to neurological sequelae from surgery and radiation therapy, thus alternative approaches are in critical need. As molecular targets underlying various cancers become more clearly defined, there is an increasing push for targeted gene therapies. Viral vectors and nonviral nanoparticles have been thoroughly investigated for gene delivery and show promise as vectors for gene therapy for pediatric brain cancer. Here, we review inorganic and organic materials in development for nanoparticle gene delivery to the brain with a particular focus on safety.

Original languageEnglish (US)
Pages (from-to)1805-1815
Number of pages11
JournalNanomedicine
Volume15
Issue number18
DOIs
StatePublished - Aug 2020

Keywords

  • Brain tumor
  • Gene delivery
  • Nanoparticles
  • Pediatrics
  • Safety

ASJC Scopus subject areas

  • Bioengineering
  • Medicine (miscellaneous)
  • Biomedical Engineering
  • Materials Science(all)

Fingerprint Dive into the research topics of 'Safety considerations for nanoparticle gene delivery in pediatric brain tumors'. Together they form a unique fingerprint.

Cite this